SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-296630
Filing Date
2023-12-15
Accepted
2023-12-15 16:05:35
Documents
14
Period of Report
2023-12-13
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d602391d8k.htm   iXBRL 8-K 27879
2 EX-3.1 d602391dex31.htm EX-3.1 186793
3 EX-3.2 d602391dex32.htm EX-3.2 265147
  Complete submission text file 0001193125-23-296630.txt   701097

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA phat-20231213.xsd EX-101.SCH 2869
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE phat-20231213_lab.xml EX-101.LAB 19483
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phat-20231213_pre.xml EX-101.PRE 12166
8 EXTRACTED XBRL INSTANCE DOCUMENT d602391d8k_htm.xml XML 3683
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39094 | Film No.: 231490294
SIC: 2834 Pharmaceutical Preparations